Xcout IntelBobcatBio, Inc. competitors & alternatives
The 12 closest competitors and alternatives to BobcatBio, Inc. among drug discovery companies — ranked by similarity to what BobcatBio, Inc. actually does, not by market-cap band.
Subscribe to see BobcatBio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About BobcatBio, Inc.
BobcatBio, Inc. is a clinical-stage biotechnology company founded in 2020 and headquartered in Hummelstown, Pennsylvania. The company focuses on developing macrophage-based cell therapies and cancer-specific immunotherapies, including its lead cellular therapy candidate RB-1355, for the treatment of solid tumors.
BobcatBio, Inc. at a glance
BobcatBio, Inc. is a drug discovery company headquartered in United States. Its most recent funding round raised $5.3M in February 2025. Xcout tracks 10 named people at BobcatBio, Inc., including Stephen C. Rocamboli (CEO).
BobcatBio, Inc. leadership
- Stephen C. RocamboliCEO
- Stephen C. RocamboliExecutive Officer
- Rifat C. PamukcuDirector
- Rifat PamukcuDirector
- Robert C. TowarnickiDirector
- Robert TowarnickiDirector
4 more named people on record for BobcatBio, Inc., with roles, board committees and tenure — see the full roster →
BobcatBio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 BobcatBio, Inc. competitors
Ranked by semantic similarity — how close each company is to BobcatBio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Similar drug discovery company
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Similar drug discovery company
Vivacta Biotechnology is a biopharmaceutical company headquartered in Shanghai, China, specializing in innovative biotechnology research. The company is focused on developing in vivo CAR-T therapies utilizing a targeted delivery system.
Similar drug discovery company
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
Biopharma
Scout Bio, Inc. is a veterinary biotechnology company specializing in animal health and advanced gene therapy treatments currently being evaluated in clinical trials.
Similar drug discovery company
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Innovative therapies for serious diseases
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company headquartered in Thousand Oaks, California. The company develops novel treatments for patients with cancer and autoimmune diseases.
Biopharmaceuticals
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Biopharmaceuticals
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.
Biopharmaceuticals
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for oncology and is based in Toronto, Canada, with a corporate office in Boston, Massachusetts.
Biotherapeutics
Headquartered in South San Francisco, California, Chimera Bioengineering is a privately held biotechnology company focused on developing advanced cellular engineering technologies for cancer therapies.
Cell & gene therapy
Complement Therapeutics is a clinical-stage biotechnology company headquartered in Munich, Germany, that develops precision therapies for complement-mediated diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of BobcatBio, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BobcatBio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →